Bioventus reiterates 2026 guidance after FDA device reclassification

Go back to Bioventus reiterates 2026 guidance after FDA device reclassification
Global Beverage Solutions, Inc. (NASDAQ: BVS) Delayed: 14.96 -0.08 (0.53%)
Previous Close $15.04    52 Week High $0.01 
Open $14.94    52 Week Low $0.01 
Day High $15.09    P/E N/A 
Day Low $14.76    EPS $0.00 
Volume 387,051